WESTLAKE VILLAGE, Calif., March 18, 2015 /PRNewswire/ — Envy Medical, Inc. launches SilkPeel3, the next generation of its world class patented Advanced Dermalinfusion Technology. Unveiled originally in 2005, SilkPeel is celebrating its 10th birthday in style with fresh features, enhanced functionality and a sleek new design.
In the past decade, SilkPeel has expanded to over 40 countries, with 3,000 systems in use worldwide. It has also developed a solid celebrity fan base thanks to the gentle, non-irritating technology and immediate “wow” factor. A longtime favorite of A-listers, SilkPeel is one of the most coveted treatments at destination spas like The Spa at Four Seasons Hotel Los Angeles at Beverly Hills with a following that includes Katie Couric and the Olsen twins.
As the first and only true Dermalinfusion system, SilkPeel combines non-invasive exfoliation with the delivery of condition-specific solutions under pressure. These solutions are targeted toward the individual skin needs of the client and can address acne, dryness, dull skin, aging, sun damage and pigmentation.
“Our R&D team has been listening to doctors and skincare professionals as they have expanded their use of Dermalinfusion, treating new areas of the body and skin textural issues,” says Curtis Cluff, CEO of Envy Medical, Inc. “Based on their feedback, we upgraded the SilkPeel design, improved the features and enhanced the functions to exceed the expanding needs of our clients.”
SilkPeel3 is an exponential advancement in ease-of-use, functionality, and efficacy. It is sleeker, more compact and has an innovative “IndiviDUAL Infusion” dual-port design that loads two serum solutions at once, allowing for more tailored treatments that address multiple skin concerns. SilkPeel3 can now treat blemishes, dry skin, dark spots and a host of other common skin concerns in one quick and simple session.
“The dual-port design will make combination treatments catering directly to individual needs a reality,” says Felipe Jimenez, Ph.D., Envy’s Chief Scientific Officer. “For a patient with combination skin, we can use an infusion of ClarityMD across the oily T-zone and then switch to a hydrating solution for drier areas, ensuring optimal results for all skin types.” Continues Dr. Jimenez, “For our providers, SilkPeel3 gives a wider variety of treatment offerings and protocols.”
Additional improvements include the ergonomically improved “Plexus” hand piece with the option of new disposable medical-grade stainless steel treatment tips that make the treatment more comfortable and effective by eliminating incomplete passes and delivering more powerful and precise pneumatic vacuum results. Clients will be able to see impurities being removed from their skin in real time, so they can actually visualize their skin getting cleaner.
The new SilkPeel3 offers an even wider treatment range, expanding the system’s efficacy to multiple body applications as well. When treating the body, SilkPeel3’s higher vacuum power settings improve the appearance of cellulite and restore skin elasticity, while the lower settings help address stretch marks, truncal acne and rough patches.
SilkPeel3 will launch at AAD – March 20-24 in San Francisco. Visit the Envy Medical booth (#312) to be among the first to experience the system.
A SilkPeel3 Facial will cost approximately $125 – 150, and will be available at select spas, medspas and dermatologist offices nationwide. Find SilkPeel near you.
See the SilkPeel3 difference here: http://silkpeel.com/SP3/
The SilkPeel Advanced Dermalinfusion Treatment System is a breakthrough skin rejuvenation and precision exfoliation treatment from Envy Medical, the creators of The LUMIXYL® System. @SilkPeelMD
ABOUT ENVY MEDICAL
Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with Advanced Dermalinfusion Technology for deeper tissue delivery of active ingredients and better patient outcomes (www.silkpeel.com). Envy is also the developer of the patent pending ClarityMD Acne Solution brand of acne treatment products (www.claritymdacne.com) and is the exclusive worldwide licensor of skin brightening peptides, including the Lumixyl® peptide, developed at Stanford University (www.lumixyl.com). More information can be found at http://www.envymedical.com. @Envymedical @LUMIXYL @ClarityMDAcne.